MONEY

Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-™T) at 2024 CSCO Congress

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 29, 2024 - 12:00
Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-™T) at 2024 CSCO Congress
Read More

Tags:

Previous Article

Inside the making—and evolution—of ‘Domo on Data’ blogs

Next Article

Argentina's Milei predicts 2025 election shakeup at party launch

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Central Iron Ore Limited: Drilling Results Finalised

Central Iron Ore Limited: Drilling Results Finalised

Tomas Kauer - Mode... Sep 19, 2024

Rock Tech Announces Closing of Non-Brokered Private Placement

Rock Tech Announces Closing of Non-Brokered Private Pla...

Tomas Kauer - Mode... Oct 8, 2024

Sohu stock soars to 52-week high, touches $16.4 amid robust gains

Sohu stock soars to 52-week high, touches $16.4 amid ro...

Tomas Kauer - Mode... Oct 3, 2024